These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15926798)

  • 21. Bisubstrate inhibitors of protein kinases: from principle to practical applications.
    Lavogina D; Enkvist E; Uri A
    ChemMedChem; 2010 Jan; 5(1):23-34. PubMed ID: 19774589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pharmacophore map of small molecule protein kinase inhibitors.
    McGregor MJ
    J Chem Inf Model; 2007; 47(6):2374-82. PubMed ID: 17941626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel kinase inhibitors by reshuffling ligand functionalities across the human kinome.
    Vidović D; Muskal SM; Schürer SC
    J Chem Inf Model; 2012 Dec; 52(12):3107-15. PubMed ID: 23121521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequence and structural analysis of kinase ATP pocket residues.
    Vulpetti A; Bosotti R
    Farmaco; 2004 Oct; 59(10):759-65. PubMed ID: 15474052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strong and weak hydrogen bonds in protein-ligand complexes of kinases: a comparative study.
    Panigrahi SK
    Amino Acids; 2008 May; 34(4):617-33. PubMed ID: 18180869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-ATP competitive protein kinase inhibitors as anti-tumor therapeutics.
    Kirkland LO; McInnes C
    Biochem Pharmacol; 2009 May; 77(10):1561-71. PubMed ID: 19167366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Finding protein kinase hits using structural information.
    Cherry M; Reader J; Williams D
    Prog Med Chem; 2006; 44():1-63. PubMed ID: 16697894
    [No Abstract]   [Full Text] [Related]  

  • 28. The NTP phosphate donor in kinase reactions: is ATP a monopolist?
    Shugar D
    Acta Biochim Pol; 1996; 43(1):9-23. PubMed ID: 8790708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Progress in the design of selective ATP-competitive kinase inhibitors].
    Deng XQ; Xiang ML; Jia R; Yang SY
    Yao Xue Xue Bao; 2007 Dec; 42(12):1232-6. PubMed ID: 18338633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MALDI-TOF mass-spectrometry-based versatile method for the characterization of protein kinases.
    Kondo N; Nishimura S
    Chemistry; 2009; 15(6):1413-21. PubMed ID: 19115309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Saturation transfer difference NMR spectroscopy as a technique to investigate protein-carbohydrate interactions in solution.
    Haselhorst T; Lamerz AC; Itzstein Mv
    Methods Mol Biol; 2009; 534():375-86. PubMed ID: 19277538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluorescence labels in kinases: a high-throughput kinase binding assay for the identification of DFG-out binding ligands.
    Simard JR; Rauh D
    Methods Mol Biol; 2012; 800():95-117. PubMed ID: 21964785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NMR spectroscopic and molecular modeling investigations of the trans-sialidase from Trypanosoma cruzi.
    Haselhorst T; Wilson JC; Liakatos A; Kiefel MJ; Dyason JC; von Itzstein M
    Glycobiology; 2004 Oct; 14(10):895-907. PubMed ID: 15190004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NMR analysis of a Tau phosphorylation pattern.
    Landrieu I; Lacosse L; Leroy A; Wieruszeski JM; Trivelli X; Sillen A; Sibille N; Schwalbe H; Saxena K; Langer T; Lippens G
    J Am Chem Soc; 2006 Mar; 128(11):3575-83. PubMed ID: 16536530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The design, annotation, and application of a kinase-targeted library.
    Xi H; Lunney EA
    Methods Mol Biol; 2011; 685():279-91. PubMed ID: 20981529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of caged compounds binding to proteins by NMR spectroscopy.
    Bandorowicz-Pikula J; Buchet R; Cañada FJ; Clémancey M; Groves P; Jiménez-Barbero J; Lancelin JM; Marcillat O; Pikula S; Sekrecka-Belniak A; Strzelecka-Kiliszek A
    Biochem Biophys Res Commun; 2010 Sep; 400(3):447-51. PubMed ID: 20804737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ATP-conjugated peptide inhibitors for calmodulin-dependent protein kinase II.
    Ahn DR; Han KC; Kwon HS; Yang EG
    Bioorg Med Chem Lett; 2007 Jan; 17(1):147-51. PubMed ID: 17035012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. QSAR models for predicting the similarity in binding profiles for pairs of protein kinases and the variation of models between experimental data sets.
    Sheridan RP; Nam K; Maiorov VN; McMasters DR; Cornell WD
    J Chem Inf Model; 2009 Aug; 49(8):1974-85. PubMed ID: 19639957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and characterization of 5'-p-fluorosulfonylbenzoyl-2' (or 3')-(biotinyl)adenosine as an activity-based probe for protein kinases.
    Ratcliffe SJ; Yi T; Khandekar SS
    J Biomol Screen; 2007 Feb; 12(1):126-32. PubMed ID: 17166825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Halogen bonding at the ATP binding site of protein kinases: preferred geometry and topology of ligand binding.
    Poznański J; Shugar D
    Biochim Biophys Acta; 2013 Jul; 1834(7):1381-6. PubMed ID: 23376187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.